| Product NDC: | 55390-013 |
| Proprietary Name: | Dihydroergotamine Mesylate |
| Non Proprietary Name: | Dihydroergotamine Mesylate |
| Active Ingredient(s): | 1 mg/mL & nbsp; Dihydroergotamine Mesylate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-013 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040453 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030904 |
| Package NDC: | 55390-013-10 |
| Package Description: | 10 VIAL in 1 BOX (55390-013-10) > 1 mL in 1 VIAL |
| NDC Code | 55390-013-10 |
| Proprietary Name | Dihydroergotamine Mesylate |
| Package Description | 10 VIAL in 1 BOX (55390-013-10) > 1 mL in 1 VIAL |
| Product NDC | 55390-013 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dihydroergotamine Mesylate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20030904 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | DIHYDROERGOTAMINE MESYLATE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Ergotamine Derivative [EPC],Ergotamines [Chemical/Ingredient] |